NICE accreditation

The NICE Accreditation programme is unable to accept any new applications from September 2016.

Find out more about the changes

View all accreditation decisions

The accreditation programme assesses the processes used to produce guidance and advice. This will, in turn, help raise standards in guidance production. Please continue to use the facilities on NICE Evidence Search to search for accredited guidance.

Go to NICE Evidence Search
  • To help health and social care professionals identify the most trusted sources of guidance developed using critically evaluated high quality processes
  • To drive up the quality of information used by health and social care professionals in decision making
  • To improve patient outcomes through providing robust evidence for NICE quality standards
  • Increase the visibility of guidance and advice
  • Attain accreditation for guidance making it eligible to be considered for the development of NICE quality standards
  • Promote guideline development processes as being robust and transparent
  • Use the NICE Accreditation Mark as an indication of high standard, good quality information

Recent accreditations

Royal Pharmaceutical Society

NICE has accredited the process used by Royal Pharmaceutical Society to produce its professional guidance and standards. Accreditation is valid for 5 years from 17 February 2017 and is retrospectively applicable to guidance produced using the processes described in ‘Professional standards, guidance and frameworks, process development manual’ (2016).

The Midlands Therapeutics Review and Advisory Committee (MTRAC)

NICE has accredited the process used by the Midlands Therapeutics Review and Advisory Committee to produce Commissioning support summaries. Accreditation is valid for 5 years from 7 March 2017 and is retrospectively applicable to guidance produced using the processes described in the MTRAC Handbook (2017).

British Transplantation Society

NICE has renewed accreditation of the process used by the British Transplantation Society to produce clinical guidelines. The renewed accreditation is valid until 25 January 2022 and applies to guidance produced using the processes described in BTS Guideline Development Policy, Revised: 14 January 2016. The original accreditation term began on 25 January 2012.

Regional Drug and Therapeutics Centre

NICE has accredited the process used by the Regional Drug and Therapeutics Centre to produce New Drug Evaluations. Accreditation is valid for 5 years from 7 March 2017 and is retrospectively applicable to guidance produced using the processes described in New Drug Evaluations Process Manual v.3.0 (October 2016).

British Association of Dermatologists

NICE has accredited the process used by the British Association of Dermatologists to produce Service Guidance and Standards. Accreditation is valid for 5 years from 7 March 2017 and is retrospectively applicable to guidance produced using the processes described in Developing Dermatology Service Guidance, 2016.

Public Health England logo

National Osteoporosis Guideline Group

NICE has accredited the process used by the National Osteoporosis Guideline Group to produce Clinical guideline for the prevention and treatment of osteoporosis. Accreditation is valid for 5 years from 7 March 2017 and is retrospectively applicable to guidance produced using the processes described in NOGG protocol document (2017).

Children’s Brain Tumour Research Centre

NICE has renewed accreditation of the process used by the Children’s Brain Tumour Research Centre to produce The brain pathways guideline. The renewed accreditation is valid until 21 July 2021 and applies to guidance produced using the processes described in ‘The brain pathways guideline’ (2016). The original accreditation term began on 21 July 2011.

Accreditation Advisory Committee

Frequently asked questions

Find the answers to the most common questions we receive about accreditation.